摘要
目的 研究康莱特治疗恶性胸腔积液的临床应用价值。方法 6 0例恶性胸腔积液的患者随机分为治疗组和对照组各 30例 ,治疗组采用康莱特胸腔灌注 ,对照组采用顺铂胸腔灌注。结果 治疗组的疗效、治疗前后的免疫功能、生存期及毒副反应均明显优于对照组。结论 康莱特能有效地控制恶性胸腔积液 ,提高免疫力 ,延长生存期 ,改善生活质量。
Objective To study the clinical application value of KLT treating malignant pleural effusion. Methods Sixty cases malignant pleural effusion patients were randomly divided into study group and control group. The study group was treated by KLT perfusion into pleural cavity, the control group was treated by DDP. Results In effect immune function living time and toxicity, study group is better than control group. Conclusion KLT can effective treat malignant pleural effusion enhance immune function prolong living time improve life quality.
出处
《陕西肿瘤医学》
2002年第2期144-145,共2页
ShanXi Oncology Medicine
